The results paved the way for liraglutide, branded as Saxenda, to be approved in the US as a once-a-day subcutaneous injection in December 2014 and in Europe in 2015 for the treatment of chronic weight management combined with a reduced calorie diet and increased physical exercise (Molteni, Chen)
Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Retatrutide adds the glucagon component on top of this already effective dual mechanism
a high-fat meal is a common trigger for heartburn, even when it comes from a healthier source of fat
GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in your gut that plays a key role in regulating blood sugar and appetite
This comprehensive guide analyzes triple-receptor affinity, metabolic mechanisms, and research applications for next-generation incretin mimetics